Lewis B

Lewis B

Lewis B (Leb) is a difucosylated tetrasaccharide antigen within the histo-blood group family, defined by the structure Fucα(1→2)Galβ(1→3)[Fucα(1→4)]GlcNAcβ. It features α1-2 fucose on the terminal galactose and α1-4 fucose on the N-acetylglucosamine of a type 1 precursor chain. This distinguishes it from the monofucosylated Lewis A antigen, as Leb incorporates secretor-dependent α1-2 fucosylation while maintaining the type 1 β1-3 Gal-GlcNAc linkage. Leb is expressed in secretions of individuals with functional FUT2 and FUT3 genes, differentiating it phenotypically from Lea in non-secretors.

Biosynthetic Pathway

Biosynthesis begins with the type 1 precursor Galβ1-3GlcNAc, onto which FUT2 (secretor fucosyltransferase) adds α1-2 fucose to the galactose residue, generating H type 1. Subsequently, FUT3 catalyzes the addition of α1-4 fucose to the GlcNAc residue to yield Leb. These antigens originate primarily in the liver, pancreas, and intestinal epithelium before adsorbing onto red blood cells. FUT3’s substrate permissiveness enables the production of Lea, Leb, ALeb, and BLeb from type 1 chains. Non-secretors (se/se), who lack functional FUT2, generate only Lea when FUT3 is active, whereas secretors synthesize higher levels of difucosylated structures.

Biological Distribution and Functions

Leb is found on glycoproteins and glycolipids in plasma, milk, and mucosal secretions. It plays important roles in microbial adhesion, immune interactions, and host-pathogen dynamics within the gastrointestinal and respiratory tracts. Leb also participates in cell-cell recognition, competes with ABO antigens for glycosyltransferases, and contributes to structural diversity through differential glycosylation. In Lewis-positive secretors, elongated Leb chains are more abundant than the shorter Lea structures.

Synthetic Strategies and Applications

Chemical synthesis of Leb often uses linear strategies starting from lactose, applying thioglycoside donors to achieve selective fucosylation steps required to construct Leb hexasaccharides. These synthetic glycans are commonly conjugated for immunological studies. Automated glycan assembly further facilitates the production of type 1 Lewis antigens such as Leb, supporting research in cancer biomarkers, microbial ligand interactions, and immunolocalization. Leb structures localize predominantly to the trans-Golgi network in both mammalian and plant systems.

Resultaat van uw zoeken : 12 product gevonden

Verfijn uw zoekopdracht :

RUO
CE/IVD
NEW
  • Biochemicals
BRENG DE FILTERS AAN
INITIALISEREN


Referentie
Beschrijving
Cond.
Price Bef. VAT
OL02434-10mg
 10mg 
OL02434-25mg
 25mg 
OL09570-1000mg
 1000mg